FDA rejects Multiple Sclerosis drug Cladribine application

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

FDA rejects Multiple Sclerosis drug Cladribine application

Post by MSUK » Mon Nov 30, 2009 8:09 am

FDA rejects Multiple Sclerosis drug Cladribine application as 'incomplete'

U.S. regulators rejected as incomplete Merck KGaA's application to sell the oral treatment multiple sclerosis. Merck, the German based drugmaker will seek a meeting with the U.S. Food and Drug Administration after the agency refused to accept i...ts application for the medicine, cladribine, spokesman Gangolf Schrimpf said.......

More - http://www.msrc.co.uk/index.cfm?fuseact ... ageid=1629

User avatar
Needled
Family Elder
Posts: 361
Joined: Wed Jan 14, 2009 3:00 pm
Location: Connecticut
Contact:

Post by Needled » Mon Nov 30, 2009 9:18 am

Bummer. I hope it doesn't take them too long to sort it out.
I also hope Novartis does better with their app for Fingolimod. Novartis said they had been in contact with the FDA throughout the later stages of the trial, so I hope their application is complete and doesn't delay the review. They're supposed to file before the end of this year.

Post Reply
  • Similar Topics
    Replies
    Views
    Last post